A K103N resistance mutation is not an absolute contraindication to adding efavirenz to a salvage regimen: a case report.
Kolber
Michael A
MA
D000480:Alkynes; D019380:Anti-HIV Agents; D023241:Antiretroviral Therapy, Highly Active; D048588:Benzoxazines; D000075202:Contraindications; D003521:Cyclopropanes; D024921:Drug Resistance, Multiple, Viral / Q000235:genetics*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000235:genetics; D015497:HIV-1 / Q000235:genetics*; D006801:Humans; D008875:Middle Aged; D009154:Mutation / Q000235:genetics*; D010078:Oxazines; D016879:Salvage Therapy / Q000379:methods; D019562:Viral Load
D000480:Alkynes; D019380:Anti-HIV Agents; D048588:Benzoxazines; D003521:Cyclopropanes; D010078:Oxazines; C098320:efavirenz